NCT00334464View on ClinicalTrials.gov

"A Pharmacogenetic Study of Warfarin Dosing, The COUMA-GEN Study"

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

November 30, 2007

Conditions
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Interventions
DRUG

Standard of care or genotyping dosing of warfarin dosing

Trial Locations (1)

84143

LDS Hospital, Salt Lake City

All Listed Sponsors
collaborator

Deseret Foundation

OTHER

collaborator

LDS Hospital Cardiovascular Research

UNKNOWN

lead

Intermountain Health Care, Inc.

OTHER

NCT00334464 - "A Pharmacogenetic Study of Warfarin Dosing, The COUMA-GEN Study" | Biotech Hunter | Biotech Hunter